Related Experiment Video
Updated: Jan 29, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Immune Thrombocytopenia Associated with Mycoplasma pneumoniae Infection
Catarina Gouveia1, Vasco Evangelista1, Raquel Almeida1
1Beatriz Ângelo Hospital, Loures, Portugal.
Abstract:
Immune thrombocytopenia (ITP) related to Mycoplasma pneumoniae infection is a rare condition and usually associated with a severe clinical course. We here report a case of a young man with a clinical diagnosis of severe ITP secondary to M. pneumoniae infection. The clinical features, therapy and outcome are presented.
Learning Points:
Immune thrombocytopenia (ITP) related to Mycoplasma pneumoniae infection is a rare condition.ITP secondary to M. pneumoniae infection appears to be associated with a more severe and refractory clinical course.It remains unclear whether specific anti-Mycoplasma antibiotic therapy is associated with a milder clinical course and a better prognosis.
Insights
Immune thrombocytopenia (ITP) secondary to Mycoplasma pneumoniae infection is rare and often severe. This case highlights the challenging clinical course and treatment of this condition.
Area of Science:
- Infectious Diseases
- Hematology
- Immunology
Background:
- Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
- Mycoplasma pneumoniae infection is a common respiratory pathogen.
- ITP secondary to Mycoplasma pneumoniae infection is a rare but serious complication.
Purpose of the Study:
- To report a case of severe ITP secondary to Mycoplasma pneumoniae infection.
- To describe the clinical features, therapy, and outcome of this rare condition.
- To discuss the association between Mycoplasma pneumoniae infection and ITP severity.
Main Methods:
- Case report of a young male patient.
- Clinical diagnosis of severe ITP.
- Review of clinical features, therapeutic interventions, and patient outcome.
Main Results:
- The patient presented with severe ITP.
- The condition was secondary to Mycoplasma pneumoniae infection.
- The clinical course was severe and refractory to initial treatment.
Conclusions:
- ITP associated with Mycoplasma pneumoniae infection is rare.
- This specific type of ITP often presents with a severe and refractory clinical course.
- The efficacy of anti-Mycoplasma antibiotic therapy on ITP prognosis remains uncertain.
Related Concept Videos
What is the Immune System?
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Humoral Immune Responses
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

